Stay updated on Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.

Latest updates to the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe history now includes a site-wide funding notice and a revision update to v3.4.1, replacing the former v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoChange DetectedThe history now shows a glossary toggle, color-coded change highlights (green for additions and red for deletions), and a new revision tag v3.4.0. The previous revision tag v3.3.4 is removed.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.3.3 to the revision history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check73 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedA new version dated 2025-11-12 was added, including updates to Contacts/Locations, Study Status, and Recruitment Status. A government funding notice and the prior 'Active, not recruiting' status were removed.SummaryDifference0.5%

Stay in the know with updates to Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.